Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
药物滥用障碍、丙型肝炎病毒和艾滋病毒治疗的健康经济学:评估个人、系统和社区的干预结果
基本信息
- 批准号:10079945
- 负责人:
- 金额:$ 164.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAlcohol or Other Drugs useAreaAwardBehaviorCaringClinicalCommunitiesConsultationsDataData LinkagesData SetDevelopmentEconomicsEducational CurriculumEnsureEvaluationEvaluation MethodologyEvaluation ResearchFunding OpportunitiesGrantHIVHIV/HCVHealthHealth Services ResearchHealth systemHealthcareHepatitis C virusIndividualInfrastructureIntegrated Health Care SystemsInterventionKnowledgeLeadLeadershipLinkMassachusettsMentorsMentorshipMethodologyMethodsModelingOutcomeOutcomes ResearchParticipantPoliciesPopulationProviderRecordsResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesScienceServicesStructureSubstance Use DisorderSystemTrainingTraining ActivityTranslatingTreatment outcomeWorkadaptive interventionadvanced simulationcomparative effectiveness studydesigneconomic evaluationexperiencehealth care service utilizationhealth economicsimplementation researchimprovedinterestknowledge baseknowledge translationmembermodels and simulationnovel strategiesprogramssymposiumtooltranslational approach
项目摘要
OVERALL PROJECT SUMMARY
In the 4.5 years since our initial award, we have established CHERISH (Center for Health Economics of
Treatment Interventions for Substance Use Disorder, HCV, and HIV) as a National Center of Excellence for
health economic research related to substance use disorder policy and HCV and HIV care of people who use
substances. Our unique multi-institutional center leverages outstanding researchers with synergistic areas of
expertise. In the initial award period, our aims have focused on addressing the needs of integrated healthcare
system payers and providers. CHERISH guidance and input has resulted in addition of critical economic
components to comparative effectiveness studies that evaluate treatments delivered to individual participants
in healthcare or SUD treatment settings, including those evaluating interventions delivered at the health-
system or organization level. In this renewal period, we propose to expand our focus to add economic
components, develop economic methodologies, and improve knowledge translation strategies for health
outcome and implementation research that is conducted at the individual, system, and community levels.
Our proposal, entitled: “Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating
Intervention Outcomes for Individuals, Systems, and Communities,” has the overall aim to develop and
disseminate health economic research on healthcare utilization, health outcomes, and health-related
behaviors that informs substance use disorder treatment policy and HCV and HIV care of people who use
substances. The Center includes 3 Research Support Cores (Methodology Core, Population Data & Modeling
Core, and Dissemination & Policy Core), a Pilot Grant & Training Core that serves as the Pilot Research Project
Core, and an Administrative Core. The Methodology Core will continue its highly successful Consultation
Service and will develop new methods related to economic evaluation in implementation studies and adaptive
interventions. The new Population Data & Modeling Core will draw on recent experience of Core members in
Massachusetts to promote new approaches to state data linkages for population-level economic evaluations,
and will support a research consortium that advances simulation modeling methods for these populations. The
Dissemination & Policy Core will continue to engage in dissemination science activities that directly assist
research teams and further the science, continue to hold bi-annual stakeholder conferences, and develop a new
knowledge dissemination curriculum. The Pilot Grant & Training Core will continue to use experts from the
other Cores and Research Affiliates to select, evaluate, and mentor competitive pilot grant awardees, will
conduct new training and mentorship activities, and will lead a diversity initiative for the Center. The
Administrative Core will continue to provide infrastructure and leadership to all Cores.
总体项目摘要
自首次奖励以来的4。5年中,我们建立了珍贵(
药物使用障碍,HCV和HIV的治疗干预措施)ASA国家卓越中心
与使用物质使用障碍政策以及使用的HCV和HIV护理有关的健康经济研究
物质。
专业知识。
系统付款人和提供商。
比较有效性研究的组成部分研究提供给个人参与者的治疗
在医疗保健或SUD治疗环境中,包括评估在健康中提供的干预措施的情况
系统或组织级别。
组成部分,开发经济方法论和侵害健康的翻译策略
在个人,系统和社区层面进行的结果和实施研究。
我们的建议,题为:“卫生经济学使用障碍,HCV和HIV治疗:评估:评估
对个人,系统和社区的干预结果“具有发展和发展的总体目标
传播有关医疗保健利用,健康结果和与健康有关的健康经济研究
为使用毒品障碍政策和艾滋病毒照顾的行为
该中心包括3个研究支持核心(方法核心,人口数据和建模
核心,显示与政策核心),一个试点赠款和培训核心,作为试点研究项目
核心和行政核心。
在实施研究和适应性的经济评估和适应性的经济评估相关的服务和新方法
IntervatutuationNtts。
马萨诸塞州促进新的方法来实现人口级经济评估的数据联系,
并将支持一个研究这些人群的模拟方法的研究联盟
传播和政策核心核心继续进行传播科学,以肯定的是
研究团队和进一步的科学,继续举行两年一次的利益持有人会议,并开发新的
知识传播课程。
其他核心和研究分支机构,以选择,评估和指导竞争性飞行员赠款,威尔德斯
进行新的培训和指导活动
行政核心将继续为所有核心提供基础设施和领导力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce R Schackman其他文献
Bruce R Schackman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce R Schackman', 18)}}的其他基金
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学
- 批准号:
9506377 - 财政年份:2017
- 资助金额:
$ 164.75万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
物质使用障碍、HCV 和 HIV 治疗的健康经济学:评估个人、系统和社区的干预结果
- 批准号:
10208836 - 财政年份:2015
- 资助金额:
$ 164.75万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学
- 批准号:
9793440 - 财政年份:2015
- 资助金额:
$ 164.75万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
药物滥用障碍、丙型肝炎病毒和艾滋病毒治疗的健康经济学:评估个人、系统和社区的干预结果
- 批准号:
10597210 - 财政年份:2015
- 资助金额:
$ 164.75万 - 项目类别:
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
综合医疗保健时代药物滥用、丙型肝炎和艾滋病毒治疗的卫生经济学
- 批准号:
9110938 - 财政年份:2015
- 资助金额:
$ 164.75万 - 项目类别:
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorder
患有或不患有创伤后应激障碍的个人在与阿片类药物使用障碍 (OUD) 治疗提供者合作后利用医疗服务
- 批准号:
10355194 - 财政年份:2015
- 资助金额:
$ 164.75万 - 项目类别:
相似海外基金
Advancing womenâÂÂs health through research: the UNC WRHR Career Development Program
通过研究促进女性健康:北卡罗来纳大学 WRHR 职业发展计划
- 批准号:
10063712 - 财政年份:2020
- 资助金额:
$ 164.75万 - 项目类别:
Mechanisms of social identity, social networks, and recovery capital: Implications for recovery
社会认同、社交网络和恢复资本的机制:对恢复的影响
- 批准号:
10039438 - 财政年份:2020
- 资助金额:
$ 164.75万 - 项目类别:
Addressing health disparities by providing evidence-based treatment in the Black Church
通过在黑人教会提供循证治疗来解决健康差异
- 批准号:
10100442 - 财政年份:2020
- 资助金额:
$ 164.75万 - 项目类别:
Activity spaces for HIV risk and prevention among diverse men who have sex with men in Los Angeles
洛杉矶不同男男性行为者的艾滋病毒风险和预防活动空间
- 批准号:
10081422 - 财政年份:2020
- 资助金额:
$ 164.75万 - 项目类别:
Age of Initiation of Tobacco Products among USA Youth and Young Adults: Administrative Supplement
美国青少年开始使用烟草制品的年龄:行政补充
- 批准号:
10159592 - 财政年份:2020
- 资助金额:
$ 164.75万 - 项目类别: